Your Cart

  • Your cart is empty!
5% off
0 Reviews

Lijenta-M 850

In stock
৳114.00৳120.00

⛨ Tablet - (2.5mg+850mg)  
8 Tablets (1 Strip)

Estimated delivery:18 Apr - 21 Apr

SKU:

E-9354

Categories:

Medicine
  • 100% Original Products

    100% Original Products

  • Fast Delivery within 24-72 Hours

    Fast Delivery within 24-72 Hours

  • Cash On Delivery Available

    Cash On Delivery Available

  • 24/7 Order Support via whatsapp

    24/7 Order Support via whatsapp

Lijenta-M 850     

Presentation:Lijenta-M 850 tablets contain 2.5 mg of linagliptin and 850 mg of metformin hydrochloride.They are typically film-coated and available in blister packs.

Indications:Lijenta-M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus whentreatment with both linagliptin and metformin is appropriate.  

Dosage and Administration:The dosage of Lijenta-M should be individualizedbased on the patient's current regimen. It is usually taken twice daily with meals to reduce the gastrointestinal side effects associated with metformin.  

  • For patients not currently treated with metformin: The starting dose is 2.5 mg linagliptin/500 mg metformin hydrochloride twice daily. Your doctor may adjust this based on your response.
  • For patients already treated with metformin 850 mg twice daily:The starting dose is 2.5 mg linagliptin added to their current metformin dose, taken twice daily.  
  • For patients already treated with metformin 1000 mg twice daily: It is not recommended to initiate with Lijenta-M. The maximum recommended daily dose is 5 mg of linagliptin and 2000 mg of metformin hydrochloride. Renal function should be assessed before initiating Lijenta-M and periodically thereafter. Lijenta-M is contraindicated in patients with an eGFR below 30 mL/min/1.73 m².  

Side Effects:Common side effects may include diarrhea, nausea, vomiting, upset stomach, headache, and nasopharyngitis.Hypoglycemia may occur when Lijenta-M is used in combination with insulin or sulfonylureas.Pancreatitis has been reported with linagliptin.  

Precautions:Lijenta-M is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute metabolic acidosis, including diabetic ketoacidosis, and known hypersensitivity to linagliptin, metformin, or any of the excipients.It is not recommended for use in patients with type 1 diabetes mellitus. Assess renal function before initiation and monitor periodically. Avoid excessive alcohol intake. Caution should be exercised in patients with a history of pancreatitis.

Storage: Store below 30°C. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice. As you are in Bangladesh, always refer to local medical guidelines and consult a healthcare professional registered in Bangladesh for any health concerns or before taking any medication.

Comment

Add your review

Your email address will not be published. Required fields are marked *

Please login to write review!

Upload photos

Looks like there are no reviews yet.

Your experience on this site will be improved by allowing cookies.